Alexander Joseph Rossi, MD
Colorectal Surgery, Gastrointestinal Surgery
Telehealth is available
Patient type treated
Child, Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Board Certified in
Surgery General
Titles
- Assistant Professor of Surgery ( Colon & Rectal)
Education & Training
- Fellow in Colon & Rectal SurgeryThe Ochsner Clinic (2025)
- Resident in General SurgeryRutgers - Robert Wood Johnson Medical School (2024)
- Clinical Fellow in Surgical OncologyNational Institutes of Health | National Cancer Institute (2021)
- Intern in General SurgeryRutgers - Robert Wood Johnson Medical School (2018)
- MDPennsylvania State University College of Medicine, Medical Doctor (2017)
- BSState University of New York - College at Geneseo, Biology (2012)
Additional Information
Honors & Recognitions
- Excellence in Minimally Invasive and Robotic Surgical Technique: Society of Laproscopic Surgery (2024)
- General Surgery Resident of the Year: Rutgers - Robert Wood Johnson Medical School - General Surgery Residency (2024)
- The Cecal Seeker Award - Excellence in Endoscopy: Rutgers - Robert Wood Johnson Medical School - Department of Surgery - Division of Colorectal Surgery (2024)
- Leadership in Quality Improvement: St. Peter's University Hospital Healthcare System (2024)
- James W. Mackenzie, M.D., F.A.C.S. Award for Excellence in Visionary Leadership: Rutgers - Robert Wood Johnson Medical School (2023), (2024)
- John H. Landor, M.D., F.A.C.S Award for Excellence in Teaching: Rutgers - Robert Wood Johnson Medical School (2022)
- Best Oral Presentation: New Jersey Society of Colon and Rectal Surgeons (2021)
- National Cancer Institute Surgeon Scientist Award: National Institutes of Health | National Cancer Institute (2021)
- Academic Achievement Award: Rutgers - Robert Wood Johnson Medical School (2018), (2020), (2022)
- Excellence in Medical Student Teaching: Rutgers - Robert Wood Johnson Medical School (2018)
Board Certifications
- AB of Surgery, Surgery General (2024)
Publications
- Sinha S, Panda A, Xavier das Neves R, Nwosu Z, Xu K, van Beek E, Desai P, Sindiri S, Chempati S, Remmert K, Gasmi B, Bojmar L, Zambirinis C, Rossi A, Ayabe R, Wach M, McDonald J, Ruff S, Verbus E, Saif A, Eade A, Larrain C, Friedman L, Gupta S, Ranjan A, Teke M, Khan T, Pu T, Sarvestani A, Ryan C, Lambdin J, Luberice K, Gregory S, Lux S, Hong H, Luna A, Alexander I, Akmal S, Rehman S, Rainey A, Prickett T, Koparde V, Sevilla S, Kuhn S, Chan K, Sun Z, Bubunenko N, Li E, Hannah C, Gaga G, Andresson T, Cam M, Wu X, Jenkins L, Blakely A, Davis J, Trinchieri G, Singh P, Yang J, Pasca di Magliano M, Lyssiotis C, Yaffe M, Shevach E, Hernandez J. Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth. Cancer Discovery 2025, of1-of30. PMID: 41025961, DOI: 10.1158/2159-8290.cd-24-1055.
- Sinha S, Panda A, Xavier das Neves R, Nwosu Z, Xu K, van Beek E, Desai P, Sindiri S, Chempati S, Remmert K, Gasmi B, Bojmar L, Zambirinis C, Rossi A, Ayabe R, Wach M, McDonald J, Ruff S, Verbus E, Saif A, Eade A, Larrain C, Friedman L, Gupta S, Ranjan A, Teke M, Khan T, Pu T, Sarvestani A, Ryan C, Lambdin J, Luberice K, Gregory S, Lux S, Hong H, Luna A, Alexander I, Akmal S, Rehman S, Rainey A, Prickett T, Koparde V, Sevilla S, Kuhn S, Chan K, Sun Z, Bubunenko N, Li E, Hannah C, Gaga G, Andresson T, Cam M, Wu X, Jenkins L, Blakely A, Davis J, Trinchieri G, Singh P, Yang J, Pasca di Magliano M, Lyssiotis C, Yaffe M, Shevach E, Hernandez J. Expression of IMPACT curtails metabolic plasticity and augments NK cell killing to abrogate metastatic growth. Cancer Discovery 2025, of1-of30. PMID: 40736016, DOI: 10.1158/2159-8290.cd-24-1055.
- Rossi A, Verbus E, Faries M, Moncrieff M, Henderson M, Hernandez J, Lowe M. A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II). Annals Of Surgical Oncology 2022, 29: 4050-4051. PMID: 35451728, DOI: 10.1245/s10434-022-11766-z.
- Khan T, Verbus E, Rossi A, Hernandez J, Davis J, Coakley B, Blakely A. Patient demographics, clinicopathologic features, and outcomes in wild-type gastrointestinal stromal tumor: a national cohort analysis. Scientific Reports 2022, 12: 5774. PMID: 35388076, PMCID: PMC8987058, DOI: 10.1038/s41598-022-09745-1.
- Teke M, Rossi A, Hernandez J, Gastman B. Pembrolizumab Compared with Standard-of-Care Observation in Treating Patients with Completely Resected Stage I–III Merkel Cell Cancer (STAMP). Annals Of Surgical Oncology 2022, 29: 3379-3380. PMID: 35258767, DOI: 10.1245/s10434-022-11498-0.
- Saif A, Rossi A, Sarnaik A, Hernandez J, Zager J. Efficacy of Neoadjuvant Intratumoral Darleukin/Fibromun (L19IL2 + L19TNF) in Patients with Clinical Stage IIIB/C Melanoma (Neo-DREAM). Annals Of Surgical Oncology 2022, 29: 3377-3378. PMID: 35229218, DOI: 10.1245/s10434-022-11447-x.
- Gamble L, Rossi A, Fasaye G, Kesserwan C, Hernandez J, Blakely A, Davis J. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk. JAMA Surgery 2022, 157: 18-22. PMID: 34643667, PMCID: PMC8515254, DOI: 10.1001/jamasurg.2021.5118.
- Verbus E, Rossi A, Clark A, Taunk N, Nayak A, Hernandez J, Tchou J. Preoperative Use of a Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer. Annals Of Surgical Oncology 2021, 29: 1530-1532. PMID: 34783947, DOI: 10.1245/s10434-021-10987-y.
- Khan TM, Rossi AJ, Suman V, Haffty B, Hernandez JM, Boughey JC. Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy? Annals Of Surgical Oncology 2021, 29: 1526-1527. PMID: 34671883, DOI: 10.1245/s10434-021-10830-4.
- Rossi A, Verbus E, Horst K, De Martini W, Allison K, Hernandez J, Wapnir I. Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS). Annals Of Surgical Oncology 2021, 29: 1528-1529. PMID: 34471985, DOI: 10.1245/s10434-021-10552-7.
- Verbus E, Rossi A, Teke M, Nugent F, Hernandez J. Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) as a Bridge to Transplant in Unresectable Hepatocellular Carcinoma. Annals Of Surgical Oncology 2021, 29: 33-34. PMID: 34117572, DOI: 10.1245/s10434-021-10278-6.
- Rossi A, Khan T, Saif A, Marron T, Hernandez J. Treatment of Hepatocellular Carcinoma with Neoadjuvant Nivolumab Alone Versus in Combination with a CCR2/5 Inhibitor or an Anti-IL-8 Antibody. Annals Of Surgical Oncology 2021, 29: 30-32. PMID: 34117573, DOI: 10.1245/s10434-021-10269-7.
- Rossi A, Khan T, Luna A, Cercek A, Jarnagin W, Hernandez J. Hepatic Artery Infusion Pump (HAIP) Therapy Versus Chemotherapy in the First-Line Setting for Patients with Unresectable Intrahepatic Cholangiocarcinoma. Annals Of Surgical Oncology 2021, 29: 35-36. PMID: 34117578, PMCID: PMC8720372, DOI: 10.1245/s10434-021-10279-5.
- Rossi A, Khan T, Rehman S, Nash G, Hernandez J. Early Postoperative Intraperitoneal Versus Hyperthermic Intraperitoneal Chemotherapy After Optimal Cytoreductive Surgery for Colorectal Cancer with Isolated Peritoneal Metastasis (ICARuS). Annals Of Surgical Oncology 2021, 28: 4100-4101. PMID: 34032959, DOI: 10.1245/s10434-021-10110-1.
- Verbus E, Rossi A, Luna A, Iqbal A, Morris V, Hernandez J. Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA). Annals Of Surgical Oncology 2021, 28: 4095-4097. PMID: 33999346, DOI: 10.1245/s10434-021-10112-z.
- Rossi A, Khan T, Hong H, Lesinski G, Wu C, Hernandez J. Pepinemab (Anti-SEMA4D) in Combination with Ipilimumab or Nivolumab for Patients with Resectable Pancreatic and Colorectal Cancer. Annals Of Surgical Oncology 2021, 28: 4098-4099. PMID: 33987757, DOI: 10.1245/s10434-021-10111-0.
- Gupta S, McDonald J, Ayabe R, Khan T, Gamble L, Rossi A, Sinha S, Hannah C, Mabry-Hrones D, Monge B. M, Blakely A, Greten T, Davis J, Hernandez J. Perioperative MVT-5873, a fully human monoclonal antibody against a CA 19-9 epitope, for operable CA 19-9 producing pancreatic cancers, cholangiocarcinomas, and metastatic colorectal cancers. Journal Of Clinical Oncology 2020, 38: tps4655-tps4655. DOI: 10.1200/jco.2020.38.15_suppl.tps4655.
Departments and Programs
Titles
- Assistant Professor of Surgery ( Colon & Rectal)
Education & Training
- Fellow in Colon & Rectal SurgeryThe Ochsner Clinic (2025)
- Resident in General SurgeryRutgers - Robert Wood Johnson Medical School (2024)
- Clinical Fellow in Surgical OncologyNational Institutes of Health | National Cancer Institute (2021)
- Intern in General SurgeryRutgers - Robert Wood Johnson Medical School (2018)
- MDPennsylvania State University College of Medicine, Medical Doctor (2017)
- BSState University of New York - College at Geneseo, Biology (2012)
Additional Information
Honors & Recognitions
- Excellence in Minimally Invasive and Robotic Surgical Technique: Society of Laproscopic Surgery (2024)
- General Surgery Resident of the Year: Rutgers - Robert Wood Johnson Medical School - General Surgery Residency (2024)
- The Cecal Seeker Award - Excellence in Endoscopy: Rutgers - Robert Wood Johnson Medical School - Department of Surgery - Division of Colorectal Surgery (2024)
- Leadership in Quality Improvement: St. Peter's University Hospital Healthcare System (2024)
- James W. Mackenzie, M.D., F.A.C.S. Award for Excellence in Visionary Leadership: Rutgers - Robert Wood Johnson Medical School (2023), (2024)
- John H. Landor, M.D., F.A.C.S Award for Excellence in Teaching: Rutgers - Robert Wood Johnson Medical School (2022)
- Best Oral Presentation: New Jersey Society of Colon and Rectal Surgeons (2021)
- National Cancer Institute Surgeon Scientist Award: National Institutes of Health | National Cancer Institute (2021)
- Academic Achievement Award: Rutgers - Robert Wood Johnson Medical School (2018), (2020), (2022)
- Excellence in Medical Student Teaching: Rutgers - Robert Wood Johnson Medical School (2018)
Board Certifications
- AB of Surgery, Surgery General (2024)
Publications
- Sinha S, Panda A, Xavier das Neves R, Nwosu Z, Xu K, van Beek E, Desai P, Sindiri S, Chempati S, Remmert K, Gasmi B, Bojmar L, Zambirinis C, Rossi A, Ayabe R, Wach M, McDonald J, Ruff S, Verbus E, Saif A, Eade A, Larrain C, Friedman L, Gupta S, Ranjan A, Teke M, Khan T, Pu T, Sarvestani A, Ryan C, Lambdin J, Luberice K, Gregory S, Lux S, Hong H, Luna A, Alexander I, Akmal S, Rehman S, Rainey A, Prickett T, Koparde V, Sevilla S, Kuhn S, Chan K, Sun Z, Bubunenko N, Li E, Hannah C, Gaga G, Andresson T, Cam M, Wu X, Jenkins L, Blakely A, Davis J, Trinchieri G, Singh P, Yang J, Pasca di Magliano M, Lyssiotis C, Yaffe M, Shevach E, Hernandez J. Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth. Cancer Discovery 2025, of1-of30. PMID: 41025961, DOI: 10.1158/2159-8290.cd-24-1055.
- Sinha S, Panda A, Xavier das Neves R, Nwosu Z, Xu K, van Beek E, Desai P, Sindiri S, Chempati S, Remmert K, Gasmi B, Bojmar L, Zambirinis C, Rossi A, Ayabe R, Wach M, McDonald J, Ruff S, Verbus E, Saif A, Eade A, Larrain C, Friedman L, Gupta S, Ranjan A, Teke M, Khan T, Pu T, Sarvestani A, Ryan C, Lambdin J, Luberice K, Gregory S, Lux S, Hong H, Luna A, Alexander I, Akmal S, Rehman S, Rainey A, Prickett T, Koparde V, Sevilla S, Kuhn S, Chan K, Sun Z, Bubunenko N, Li E, Hannah C, Gaga G, Andresson T, Cam M, Wu X, Jenkins L, Blakely A, Davis J, Trinchieri G, Singh P, Yang J, Pasca di Magliano M, Lyssiotis C, Yaffe M, Shevach E, Hernandez J. Expression of IMPACT curtails metabolic plasticity and augments NK cell killing to abrogate metastatic growth. Cancer Discovery 2025, of1-of30. PMID: 40736016, DOI: 10.1158/2159-8290.cd-24-1055.
- Rossi A, Verbus E, Faries M, Moncrieff M, Henderson M, Hernandez J, Lowe M. A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II). Annals Of Surgical Oncology 2022, 29: 4050-4051. PMID: 35451728, DOI: 10.1245/s10434-022-11766-z.
- Khan T, Verbus E, Rossi A, Hernandez J, Davis J, Coakley B, Blakely A. Patient demographics, clinicopathologic features, and outcomes in wild-type gastrointestinal stromal tumor: a national cohort analysis. Scientific Reports 2022, 12: 5774. PMID: 35388076, PMCID: PMC8987058, DOI: 10.1038/s41598-022-09745-1.
- Teke M, Rossi A, Hernandez J, Gastman B. Pembrolizumab Compared with Standard-of-Care Observation in Treating Patients with Completely Resected Stage I–III Merkel Cell Cancer (STAMP). Annals Of Surgical Oncology 2022, 29: 3379-3380. PMID: 35258767, DOI: 10.1245/s10434-022-11498-0.
- Saif A, Rossi A, Sarnaik A, Hernandez J, Zager J. Efficacy of Neoadjuvant Intratumoral Darleukin/Fibromun (L19IL2 + L19TNF) in Patients with Clinical Stage IIIB/C Melanoma (Neo-DREAM). Annals Of Surgical Oncology 2022, 29: 3377-3378. PMID: 35229218, DOI: 10.1245/s10434-022-11447-x.
- Gamble L, Rossi A, Fasaye G, Kesserwan C, Hernandez J, Blakely A, Davis J. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk. JAMA Surgery 2022, 157: 18-22. PMID: 34643667, PMCID: PMC8515254, DOI: 10.1001/jamasurg.2021.5118.
- Verbus E, Rossi A, Clark A, Taunk N, Nayak A, Hernandez J, Tchou J. Preoperative Use of a Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer. Annals Of Surgical Oncology 2021, 29: 1530-1532. PMID: 34783947, DOI: 10.1245/s10434-021-10987-y.
- Khan TM, Rossi AJ, Suman V, Haffty B, Hernandez JM, Boughey JC. Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy? Annals Of Surgical Oncology 2021, 29: 1526-1527. PMID: 34671883, DOI: 10.1245/s10434-021-10830-4.
- Rossi A, Verbus E, Horst K, De Martini W, Allison K, Hernandez J, Wapnir I. Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS). Annals Of Surgical Oncology 2021, 29: 1528-1529. PMID: 34471985, DOI: 10.1245/s10434-021-10552-7.
- Verbus E, Rossi A, Teke M, Nugent F, Hernandez J. Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) as a Bridge to Transplant in Unresectable Hepatocellular Carcinoma. Annals Of Surgical Oncology 2021, 29: 33-34. PMID: 34117572, DOI: 10.1245/s10434-021-10278-6.
- Rossi A, Khan T, Saif A, Marron T, Hernandez J. Treatment of Hepatocellular Carcinoma with Neoadjuvant Nivolumab Alone Versus in Combination with a CCR2/5 Inhibitor or an Anti-IL-8 Antibody. Annals Of Surgical Oncology 2021, 29: 30-32. PMID: 34117573, DOI: 10.1245/s10434-021-10269-7.
- Rossi A, Khan T, Luna A, Cercek A, Jarnagin W, Hernandez J. Hepatic Artery Infusion Pump (HAIP) Therapy Versus Chemotherapy in the First-Line Setting for Patients with Unresectable Intrahepatic Cholangiocarcinoma. Annals Of Surgical Oncology 2021, 29: 35-36. PMID: 34117578, PMCID: PMC8720372, DOI: 10.1245/s10434-021-10279-5.
- Rossi A, Khan T, Rehman S, Nash G, Hernandez J. Early Postoperative Intraperitoneal Versus Hyperthermic Intraperitoneal Chemotherapy After Optimal Cytoreductive Surgery for Colorectal Cancer with Isolated Peritoneal Metastasis (ICARuS). Annals Of Surgical Oncology 2021, 28: 4100-4101. PMID: 34032959, DOI: 10.1245/s10434-021-10110-1.
- Verbus E, Rossi A, Luna A, Iqbal A, Morris V, Hernandez J. Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy for Patients with Stage 2A Colon Cancer (COBRA). Annals Of Surgical Oncology 2021, 28: 4095-4097. PMID: 33999346, DOI: 10.1245/s10434-021-10112-z.
- Rossi A, Khan T, Hong H, Lesinski G, Wu C, Hernandez J. Pepinemab (Anti-SEMA4D) in Combination with Ipilimumab or Nivolumab for Patients with Resectable Pancreatic and Colorectal Cancer. Annals Of Surgical Oncology 2021, 28: 4098-4099. PMID: 33987757, DOI: 10.1245/s10434-021-10111-0.
- Gupta S, McDonald J, Ayabe R, Khan T, Gamble L, Rossi A, Sinha S, Hannah C, Mabry-Hrones D, Monge B. M, Blakely A, Greten T, Davis J, Hernandez J. Perioperative MVT-5873, a fully human monoclonal antibody against a CA 19-9 epitope, for operable CA 19-9 producing pancreatic cancers, cholangiocarcinomas, and metastatic colorectal cancers. Journal Of Clinical Oncology 2020, 38: tps4655-tps4655. DOI: 10.1200/jco.2020.38.15_suppl.tps4655.
Departments and Programs